Marketing and Public RelationsInst of Clinical Research, 2006 - 74 lappuses Marketing and PR are essential parts of the pharmaceutical industry and it's associated sectors. As an industry, we would be unable to operate without creativity and innovation where marketing and PR ensure that products are placed on the market and become successful. Marketing and PR are the services that will help potential clients know that you have products that are relevant to them and beneficial for them to purchase. Understanding how marketing and PR can help you is an important aspect of R&D and business development. |
No grāmatas satura
1.–5. rezultāts no 20.
iii. lappuse
Atvainojiet, šīs lappuses saturs ir ierobežots..
Atvainojiet, šīs lappuses saturs ir ierobežots..
8. lappuse
Atvainojiet, šīs lappuses saturs ir ierobežots..
Atvainojiet, šīs lappuses saturs ir ierobežots..
10. lappuse
Atvainojiet, šīs lappuses saturs ir ierobežots..
Atvainojiet, šīs lappuses saturs ir ierobežots..
11. lappuse
Atvainojiet, šīs lappuses saturs ir ierobežots..
Atvainojiet, šīs lappuses saturs ir ierobežots..
12. lappuse
Atvainojiet, šīs lappuses saturs ir ierobežots..
Atvainojiet, šīs lappuses saturs ir ierobežots..
Saturs
Chapter 1 Introduction to Marketing and PR | 1 |
Chapter 2 Marketing and PR in clinical research | 3 |
Chapter 3 Marketing and PR in the Current Climate for Clinical Trials | 20 |
Chapter 4 Using Marketing and PR to Enhance Public Interest in Clinical Research | 35 |
Chapter 5 Working with the Marketing Department | 54 |
Summary | 68 |
71 | |
Bieži izmantoti vārdi un frāzes
ABPI activities Anon approach BABE trials benefit brand cancer Cialis clinical development clinical research clinical studies clinical trials clinicians CMR International Code of Practice commercial communication company's competition competitors costs CSDD Declaration of Helsinki developing countries diseases drug development emerging regions enrolment ensure erectile dysfunction ethical European example expenditure Figure Furthermore GlaxoSmithKline global guidelines Health healthcare hip fractures http://www.cmr.org IFPMA important increase industry's initial innovative Institute Clinical integrate marketing Internet investment Japan Pharmaceutical Manufacturers JPMA Kermani F launch Levitra Lilly ICOS major marketing and PR Marketing departments medicines Mexico organisations osteoporosis participating in clinical particular patient groups patient recruitment pharmaceutical companies pharmaceutical industry pharmaceutical market pharmaceutical product pharmaceutical R&D PhRMA population potential PR strategies Press Release programmes promotional Public Citizen Public Relations R&D and Marketing R&D personnel R&D process rival Roflumilast role scientific target therapeutic therapies treatment vardenafil Viagra websites